Image courtesy of the researchers
Study finds that aging neurons accumulate DNA damage
Reactivating an enzyme that promotes DNA repair can help to reverse age-related cognitive decline in mice.
MIT neuroscientists have discovered that an enzyme called HDAC1 is critical for repairing age-related DNA damage to genes involved in memory and other cognitive functions. This enzyme is often diminished in both Alzheimer’s patients and normally aging adults.
In a study of mice, the researchers showed that when HDAC1 is lost, a specific type of DNA damage builds up as the mice age. They also showed that they could reverse this damage and improve cognitive function with a drug that activates HDAC1.
The study suggests that restoring HDAC1 could have positive benefits for both Alzheimer’s patients and people who suffer from age-related cognitive decline, the researchers say.
“It seems that HDAC1 is really an anti-aging molecule,” says Li-Huei Tsai, the director of MIT’s Picower Institute for Learning and Memory and the senior author of the study. “I think this is a very broadly applicable basic biology finding, because nearly all of the human neurodegenerative diseases only happen during aging. I would speculate that activating HDAC1 is beneficial in many conditions.”
Picower Institute research scientist Ping-Chieh Pao is the lead author of the study, which appears today in Nature Communications.
DNA repair and aging
There are several members of the HDAC family of enzymes, and their primary function is to modify histones — proteins around which DNA is spooled. These modifications control gene expression by blocking genes in certain stretches of DNA from being copied into RNA.
In 2013, Tsai’s lab published two papers that linked HDAC1 to DNA repair in neurons. In the current paper, the researchers explored what happens when HDAC1-mediated repair fails to occur. To do that, they engineered mice in which they could knock out HDAC1 specifically in neurons and another type of brain cells called astrocytes.
For the first several months of the mice’s lives, there were no discernable differences in their DNA damage levels or behavior, compared to normal mice. However, as the mice aged, differences became more apparent. DNA damage began to accumulate in the HDAC1-deficient mice, and they also lost some of their ability to modulate synaptic plasticity — changes in the strength of the connections between neurons. The older mice lacking HCAC1 also showed impairments in tests of memory and spatial navigation.
The researchers found that HDAC1 loss led to a specific type of DNA damage called 8-oxo-guanine lesions, which are a signature of oxidative DNA damage. Studies of Alzheimer’s patients have also shown high levels of this type of DNA damage, which is often caused by accumulation of harmful metabolic byproducts. The brain’s ability to clear these byproducts often diminishes with age.
An enzyme called OGG1 is responsible for repairing this type of oxidative DNA damage, and the researchers found that HDAC1 is needed to activate OGG1. When HDAC1 is missing, OGG1 fails to turn on and DNA damage goes unrepaired. Many of the genes that the researchers found to be most susceptible to this type of damage encode ion channels, which are critical for the function of synapses.
Several years ago, Tsai and Stephen Haggarty of Harvard Medical School, who is also an author of the new study, screened libraries of small molecules in search of potential drug compounds that activate or inhibit members of the HDAC family. In the new paper, Tsai and Pao used one of these drugs, called exifone, to see if they could reverse the age-related DNA damage they saw in mice lacking HDAC1.
The researchers used exifone to treat two different mouse models of Alzheimer’s, as well as healthy older mice. In all cases, they found that the drug reduced the levels of oxidative DNA damage in the brain and improved the mice’s cognitive functions, including memory.
Exifone was approved in the 1980s in Europe to treat dementia but was later taken off the market because it caused liver damage in some patients. Tsai says she is optimistic that other, safer HDAC1-activating drugs could be worth pursuing as potential treatments for both age-related cognitive decline and Alzheimer’s disease.
“This study really positions HDAC1 as a potential new drug target for age-related phenotypes, as well as neurodegeneration-associated pathology and phenotypes,” she says.
Tsai’s lab is now exploring whether DNA damage and HDAC1 also play a role in the formation of Tau tangles — misfolded proteins in the brain that are a signature of Alzheimer’s and other neurodegenerative diseases.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Age-related cognitive decline
- Ontario Farms CBD Oil Review – Does This CBD Hemp Oil Best in Canada?on March 5, 2021 at 7:08 am
The Ontario Farms CBD has effective hemp oil to relieve pain naturally. According to users, it tastes good and works fast to relieve chronic pain and anxiety-related issues. Read on to know more about ...
- Just What the Doctor Ordered? Polygenic Test Gauges Your Alzheimer’s Riskon March 4, 2021 at 3:52 pm
As ever-larger genome-wide association studies make clear, a person’s genetic risk for Alzheimer’s disease is driven by the cumulative effects of myriad variations in their genes. The public will now ...
- The role of citrus in brain health: ‘Citrus bioactive compounds improve general cognition’on March 3, 2021 at 8:27 am
Eating citrus fruit and drinking citrus juices can have a positive impact on brain health, particularly during ageing, according to new research.
- For The Aged: Cocoa Beans Sharpens Your Memory!on March 1, 2021 at 12:01 am
Chemicals in cocoa can boost memory abilities in older people, a new study suggests. US researchers found flavanols – plant chemicals that are abundant in cocoa beans – improved performance in a ...
- Alzheimer’s and Women: How to Protect Yourselfon February 27, 2021 at 10:39 am
Women suffer from Alzheimer's at a far higher rate than men. Still, it's possible to take action to help decrease your odds of getting it.
Go deeper with Google Headlines on:
Age-related cognitive decline
Go deeper with Bing News on:
- Disruption of pathways regulated by Integrator complex in Galloway–Mowat syndrome due to WDR73 mutations | Scientific Reportson March 8, 2021 at 2:29 am
Several studies have reported WDR73 mutations to be causative of Galloway–Mowat syndrome, a rare disorder characterised by the association of neurological defects and renal-glomerular disease. In this ...
- The regulatory enzymes and protein substrates for the lysine β-hydroxybutyrylation pathwayon February 24, 2021 at 2:11 pm
Here, we report that the acyltransferase p300 can catalyze the enzymatic addition of β-hydroxybutyrate to lysine (Kbhb), while histone deacetylase 1 (HDAC1) and HDAC2 enzymatically remove Kbhb. We ...
- Distinct Ring1b complexes defined by DEAD-box helicases and EMT transcription factors synergistically enhance E-cadherin silencing in breast canceron February 18, 2021 at 4:00 pm
Analysis showed that overexpression of Complex 1 or 2 resulted in the highest Ezh2, HDAC1, H3K27me3, and H2AK119ub, and the lowest H3K27ac (substrate of HDAC1) in occupancy of E-cadherin promoter ...
- DNMT1 Stability Is Regulated by Proteins Coordinating Deubiquitination and Acetylation-Driven Ubiquitinationon February 9, 2021 at 4:01 pm
In contrast, DNMT1 was stabilized by histone deacetylase 1 (HDAC1) and the deubiquitinase HAUSP (herpes virus–associated ubiquitin-specific protease). Analysis of the abundance of DNMT1 and Tip60, as ...
- Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitoron February 3, 2021 at 4:00 pm
Treatment of cells with βOHB increased histone acetylation at the Foxo3a and Mt2 promoters, and both genes were activated by selective depletion of HDAC1 and HDAC2. Consistent with increased FOXO3A ...